0 NASDAQ Companies - February 5, 2024InterDigital Announces Convertibility of 3.50% Senior Convertible Notes Due 2027WILMINGTON, Del., Feb. 05, 2024 (GLOBE NEWSWIRE) — InterDigital, Inc. (Nasdaq: IDCC), a mobile and video technology research and development […]Read More
0 NASDAQ Companies - February 5, 2024Elicio Therapeutics to Present at the Oppenheimer 34th Annual Healthcare Life Sciences ConferenceBOSTON, Feb. 05, 2024 (GLOBE NEWSWIRE) — Elicio Therapeutics, Inc. (Nasdaq: ELTX, “Elicio Therapeutics” or “Elicio”), a clinical-stage biotechnology company developing […]Read More
0 NASDAQ Companies - February 5, 2024eFFECTOR Therapeutics to Present at Oppenheimer 34th Annual Healthcare Life Sciences ConferenceSOLANA BEACH, Calif. and REDWOOD CITY, Calif., Feb. 05, 2024 (GLOBE NEWSWIRE) — eFFECTOR Therapeutics, Inc. (NASDAQ: EFTR), a leader […]Read More
0 NASDAQ Companies - February 5, 2024Vericel to Present at the Canaccord Genuity Musculoskeletal Conference on Monday, February 12, 2024CAMBRIDGE, Mass., Feb. 05, 2024 (GLOBE NEWSWIRE) — Vericel Corporation (NASDAQ:VCEL), a leader in advanced therapies for the sports medicine […]Read More
0 NASDAQ Companies - February 5, 2024Maris-Tech Receives Order for Approximately $190,000 From a Return Customer in the Defense IndustryFor a miniature low-power solution to enhance gun sight capabilities in tactical applications Rehovot, Israel, Feb. 05, 2024 (GLOBE NEWSWIRE) […]Read More
0 NASDAQ Companies - February 5, 2024Celldex Announces Upcoming Presentation of Barzolvolimab Phase 2 Results in Chronic Spontaneous Urticaria at AAAAI 2024HAMPTON, N.J., Feb. 05, 2024 (GLOBE NEWSWIRE) — Celldex Therapeutics, Inc. (NASDAQ:CLDX) today announced that an abstract describing 12 week […]Read More
0 NASDAQ Companies - February 5, 2024Mesa Labs Announces Third Quarter ResultsLAKEWOOD, Colo., Feb. 05, 2024 (GLOBE NEWSWIRE) — Mesa Laboratories, Inc. (NASDAQ:MLAB), a global leader in the design and manufacture […]Read More
0 NASDAQ Companies - February 5, 2024Jasper Therapeutics Announces Preclinical Data Presentations at the American Academy of Allergy, Asthma, and Immunology (AAAAI) Annual MeetingREDWOOD CITY, Calif., Feb. 05, 2024 (GLOBE NEWSWIRE) — Jasper Therapeutics, Inc. (Nasdaq: JSPR) (Jasper), a biotechnology company focused on […]Read More
0 NASDAQ Companies - February 5, 2024Aclarion Announces Successful Financings; Plans to Launch CLARITY Trial and Provides Update on Next Steps of Alphatec Strategic PartnershipCompany is initiating its pivotal multicenter, prospective, randomized CLARITY trial to build on clinical evidence demonstrating superior surgical outcomes when […]Read More
0 NASDAQ Companies - February 5, 2024Pineapple Energy Prices $1.0 Million Registered Direct Offering of Common StockMINNETONKA, Minn., Feb. 05, 2024 (GLOBE NEWSWIRE) — Pineapple Energy Inc. (NASDAQ: PEGY) (“Pineapple” or the “Company”), a leading provider […]Read More